Page last updated: 2024-12-07

methyl mandelate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Methyl mandelate is an organic compound with the formula C9H10O3. It is a colorless liquid with a sweet, almond-like odor. It is a chiral compound, and the naturally occurring form is the (R)-enantiomer. Methyl mandelate can be synthesized from mandelic acid by reacting it with methanol in the presence of an acid catalyst. Methyl mandelate is used as a fragrance ingredient, and it is also a precursor to other important chemicals. It is also a common substrate for enzymatic reactions, and it is used in the study of enzyme kinetics. Methyl mandelate has been shown to have anti-inflammatory and analgesic properties. It is also being investigated for its potential therapeutic effects in the treatment of Alzheimer's disease.'

methyl mandelate: RN given for (DL)-isomer; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID78066
CHEMBL ID3039009
CHEBI ID180578
SCHEMBL ID186898
MeSH IDM0370842

Synonyms (88)

Synonym
AC-19777
CHEBI:180578
methyl 2-hydroxy-2-phenylacetate
einecs 212-240-5
nsc 6539
einecs 224-434-7
benzeneacetic acid, alpha-hydroxy-, methyl ester
ai3-01787
methyl (1)-glycolate
methyl mandelic acid
mandelic acid, methyl ester
771-90-4
methyl mandelate
nsc6539
nsc-6539
methyl dl-mandelate
DIVK1C_006255
KBIO1_001199
SDCCGMLS-0066431.P001
methyl phenylglycolate
SPECTRUM_000182
NCGC00178972-01
SPECTRUM5_000290
BSPBIO_001833
methyl dl-mandelate, 97%
KBIOGR_001910
KBIO2_000662
KBIOSS_000662
KBIO3_001333
KBIO2_005798
KBIO2_003230
SPECTRUM4_001435
SPBIO_000103
SPECPLUS_000159
SPECTRUM3_000217
SPECTRUM2_000182
r-(-)-mandelic acid methyl ester
dl-mandelic acid methyl ester
4358-87-6
FT-0694111
FT-0652548
M0040
methyl hydroxy(phenyl)acetate
AKOS005721168
mandelic acid methyl ester
methyl 2-oxidanyl-2-phenyl-ethanoate
A826336
2-hydroxy-2-phenylacetic acid methyl ester
A815200
CCG-38390
STL146357
FT-0605070
FT-0628349
hydroxy-phenyl-acetic acid methyl ester;(+)-methyl (s)-alpha-hydroxyphenylacetate
CHEMBL3039009
benzeneacetic acid, .alpha.-hydroxy-, methyl ester
AM81400
BBL027464
SCHEMBL186898
SY003754
SY003762
hydroxyl-phenyl-acetic acid methyl ester
methyl (+/-)-mandelate
(+/-)-methyl mandelate
methyl hydroxyphenylacetate
hydroxyphenylacetic acid methyl ester
methyldl-mandelate
methyl 2-hydroxy-2-phenylethanoate
benzeneacetic acid, .alpha.-hydroxy-, methyl ester, (.+/-.)-
dl-mandelic acid, methyl ester
mfcd00004493
methyl 2-phenylglycolate
SR-05000002394-1
sr-05000002394
homatropine methylbromide imp. f (ep); methyl (2rs)-2-hydroxy-2-phenylacetate; methyl mandelate; homatropine methylbromide impurity f
methyl (2rs)-2-hydroxy-2-phenylacetate (methyl mandelate)
F0001-0757
DS-4928
DTXSID30871907
(+/-)-mandelic acid methyl ester; (+/-)-methyl mandelate
D70330
()-mandelic acid methyl ester; ()-methyl mandelate
( inverted exclamation marka)-a-hydroxyphenyl acetic acid methylester
CS-0016959
EN300-129867
Z19752945
SY057133
osm-s-336
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
benzenesAny benzenoid aromatic compound consisting of the benzene skeleton and its substituted derivatives.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (4)

Assay IDTitleYearJournalArticle
AID977602Inhibition of sodium fluorescein uptake in OATP1B3-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
AID977599Inhibition of sodium fluorescein uptake in OATP1B1-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
AID1159607Screen for inhibitors of RMI FANCM (MM2) intereaction2016Journal of biomolecular screening, Jul, Volume: 21, Issue:6
A High-Throughput Screening Strategy to Identify Protein-Protein Interaction Inhibitors That Block the Fanconi Anemia DNA Repair Pathway.
AID1159550Human Phosphogluconate dehydrogenase (6PGD) Inhibitor Screening2015Nature cell biology, Nov, Volume: 17, Issue:11
6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (20)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (5.00)18.7374
1990's0 (0.00)18.2507
2000's5 (25.00)29.6817
2010's12 (60.00)24.3611
2020's2 (10.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 27.97

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index27.97 (24.57)
Research Supply Index3.04 (2.92)
Research Growth Index5.22 (4.65)
Search Engine Demand Index31.58 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (27.97)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (5.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other19 (95.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]